Menu Search
Equities

USANA Health Sciences Inc

USJ:BRN

USANA Health Sciences Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. These products support needs, such as cardiovascular health, skeletal/structural health, and digestive health, and are intended to be used in conjunction with the Essentials/CellSentials. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products.

  • Revenue in USD (TTM)974.09m
  • Net income in USD65.26m
  • Incorporated1992
  • Employees1.90k
  • Location
    USANA Health Sciences Inc3838 W Parkway BlvdSALT LAKE CITY 84120-6336United StatesUSA
  • Phone+1 (801) 954-7100
  • Fax+1 (801) 956-9486
  • Websitehttps://www.usana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		USNA:NYQ since
announced		Transaction
value
Oola Global LLCDeal completed28 Nov 202228 Nov 2022Deal completed20.92%--
Rise BarDeal completed28 Nov 202228 Nov 2022Deal completed20.92%--
Data delayed at least 15 minutes, as of Jun 07 2023 17:55 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.